1AD
Click for more information
4.00% 2.6¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-63

  1. FXm
    37,588 Posts.
    lightbulb Created with Sketch. 568
    clock Created with Sketch.
    16/04/24
    14:55
    Post #: 73369629
    Not buying to convert. So for me it's a 50/50 chance of either been able to sell them at 0.3c or even 0.4c (should we get a nice ann) for a nice profit or write them off at Tax time. A trade I'm willing to take & risk.
    Last edited by FXm: 16/04/24
    1AD Price at posting: 2.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.6¢ 		Change
0.001(4.00%) 		Mkt cap ! $15.48M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $2.302K 90.63K

Buyers (Bids)

No. Vol. Price($)
1 158374 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 437561 2
View Market Depth
Last trade - 15.26pm 28/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.